pirmagrel has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarty, S; Sheridan, DJ; Thomas, P | 1 |
| Gallas, MT; Lucchesi, BR; Mickelson, JK; Simpson, PJ | 1 |
2 other study(ies) available for pirmagrel and Cardiovascular Stroke
| Article | Year |
|---|---|
Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia.
Topics: Animals; Arrhythmias, Cardiac; Blood Platelets; Diterpenes; Ginkgolides; Hypotension; Imidazoles; Immune Sera; Lactones; Myocardial Infarction; Necrosis; Platelet Activating Factor; Platelet Activation; Pyridines; Rabbits; Thromboxane A2; Thromboxane-A Synthase | 1991 |
Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis.
Topics: Animals; Arteries; Coronary Circulation; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Hemodynamics; Imidazoles; Male; Myocardial Infarction; Pyridines; Recurrence; Streptokinase; Thromboxane-A Synthase | 1987 |